See All Slides - tctmd.com

Slides

Presentation TCT 2012

Post-Fellowship Skill Training: Proctoring and Beyond

Presenter: Paul Sorajja

October 23, 2012

Presentation TCT 2012

Viability Testing, Clinical Decision Making(2)

Presenter: Issam Mikati

October 23, 2012

Presentation TCT 2012

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

Presenter: Michael Joner

October 23, 2012

Presentation TCT 2012

Recanalization of Aortoiliac CTOs: Access Strategies and the Value of Occlusion Devices

Presenter: John Laird Jr

October 23, 2012

Presentation TCT 2012

TCT-57. Angiographic Reperfusion Indices Predict Infarct Size and Mortality: The INFUSE-AMI Trial

Presenter: Sorin Brener

October 23, 2012

Presentation TCT 2012

WATCHMAN Tips and Tricks

Presenter: Peter Sick

October 23, 2012

Presentation TCT 2012

TCT-104. Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Presenter: Ian Meredith

October 23, 2012

Presentation TCT 2012

Protagonist

Presenter: Manesh Patel

October 23, 2012

Presentation TCT 2012

TARGET I: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs an Everolimus-Eluting Stent (MicroPort)

Presenter: Run-Lin Gao

October 23, 2012

Presentation TCT 2012

MitraClip in Patients with CHF

Presenter: Stephan Baldus

October 23, 2012

Advertisement

Slides

Post-Fellowship Skill Training: Proctoring and Beyond

Viability Testing, Clinical Decision Making(2)

TCT-9. Morphological Assessment of Renal Arteries After Radiofrequency Catheter-based Sympathetic Denervation in a Porcine Model

Recanalization of Aortoiliac CTOs: Access Strategies and the Value of Occlusion Devices

TCT-57. Angiographic Reperfusion Indices Predict Infarct Size and Mortality: The INFUSE-AMI Trial

WATCHMAN Tips and Tricks

TCT-104. Feasibility Study of the Repositionable Lotus Aortic Valve Replacement System: 3-Month Outcomes in 11 Patients at High Surgical Risk (REPRISE I)

Protagonist

TARGET I: A Prospective, Randomized Trial of a Biodegradable Polymer-based Sirolimus-Eluting Stent vs an Everolimus-Eluting Stent (MicroPort)

MitraClip in Patients with CHF

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content